Skip to main content
OpenTrials
Completed

NCT Number: NCT03306914

Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients

In this study we try to review the possible effects when using modern hydroxyethylstarch solutions 6 % versus albumin 5% during living donor renal transplantation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anesthesia Morbidity

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cairo University

Cairo, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • end stage renal disease, for living donor renal transplantation

Exclusion criteria

  • severe cardiac or hepatic dysfunction, re-transplantation, coagulopathy

Treatment and study plan

Albumin resuscitation

Other

Albumin 5% is used as the intra-operative colloid

Hydroxyethylstarch resuscitation

Other

Hydroxyethyl starch 6% is used as the intra-operative colloid

albumin 5%

Drug

Infusion of Albumin 5% intra-operatively

Other names: Albumin

Hydroxyethylstarch 6%

Drug

Infusion of Hydroxyethylstarch 6% intra-operatively

Other names: Tetraspan

Primary outcomes

  1. Occurrence of complications

    Time frame: 7 days

    Increased creatinine and/or need for dialysis

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Plasma Volume Expansion for Optimum Renal Transplant Surgery: Albumin Versus Starch

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Oct 11, 2017
Registry last updated
Jan 28, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.